IGC Pharma, Inc. (IGC)
0.1974
+0.01
(+5.06%)
USD |
NYAM |
Nov 18, 16:00
0.1974
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Price to Book Value : 3.472 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 3.305 |
| November 16, 2026 | 3.078 |
| November 13, 2026 | 3.096 |
| November 12, 2026 | 3.245 |
| November 11, 2026 | 3.499 |
| November 10, 2026 | 3.448 |
| November 09, 2026 | 3.595 |
| November 06, 2026 | 3.518 |
| November 05, 2026 | 3.324 |
| November 04, 2026 | 3.430 |
| November 03, 2026 | 3.272 |
| November 02, 2026 | 3.393 |
| October 30, 2026 | 3.254 |
| October 29, 2026 | 3.504 |
| October 28, 2026 | 4.199 |
| October 27, 2026 | 4.361 |
| October 26, 2026 | 4.396 |
| October 23, 2026 | 4.327 |
| October 22, 2026 | 4.357 |
| October 21, 2026 | 4.266 |
| October 20, 2026 | 4.310 |
| October 19, 2026 | 4.257 |
| October 16, 2026 | 4.327 |
| October 15, 2026 | 4.470 |
| October 14, 2026 | 4.431 |
| Date | Value |
|---|---|
| October 13, 2026 | 4.661 |
| October 12, 2026 | 4.855 |
| October 09, 2026 | 4.924 |
| October 08, 2026 | 5.011 |
| October 07, 2026 | 4.925 |
| October 06, 2026 | 4.925 |
| October 05, 2026 | 4.960 |
| October 02, 2026 | 4.836 |
| October 01, 2026 | 4.749 |
| September 30, 2026 | 4.73 |
| September 29, 2026 | 4.468 |
| September 28, 2026 | 4.577 |
| September 25, 2026 | 4.717 |
| September 24, 2026 | 4.695 |
| September 23, 2026 | 4.779 |
| September 22, 2026 | 4.727 |
| September 21, 2026 | 4.577 |
| September 18, 2026 | 4.760 |
| September 17, 2026 | 4.450 |
| September 16, 2026 | 4.543 |
| September 15, 2026 | 4.458 |
| September 14, 2026 | 4.602 |
| September 11, 2026 | 4.653 |
| September 10, 2026 | 4.727 |
| September 09, 2026 | 4.702 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 6.986 |
| CNBX Pharmaceuticals, Inc. | -- |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 0.8630 |
| Fulcrum Therapeutics, Inc. | 0.9421 |
Price to Book Value Related Metrics
| PS Ratio | 15.74 |
| PEG Ratio | -0.0540 |
| Price | 0.1974 |
| Earnings Yield | -40.63% |
| Market Cap | 22.57M |
| PEGY Ratio | -0.0540 |